glyburide has been researched along with riboflavin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doman, TN; McGovern, SL; Seidler, J; Shoichet, BK | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Flores-Murrieta, FJ; Granados-Soto, V; Medina-Santillán, R; Reyes-García, G; Rocha-González, HI; Rodríguez-Silverio, J; Terán-Rosales, F | 1 |
| Hamid, TA; Ooi, CP; Yassin, Z | 1 |
2 review(s) available for glyburide and riboflavin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Momordica charantia for type 2 diabetes mellitus.
Topics: Diabetes Mellitus, Type 2; Glyburide; Humans; Hypoglycemic Agents; Momordica charantia; Phytotherapy; Plant Preparations; Randomized Controlled Trials as Topic; Riboflavin | 2010 |
3 other study(ies) available for glyburide and riboflavin
| Article | Year |
|---|---|
Identification and prediction of promiscuous aggregating inhibitors among known drugs.
Topics: Antifungal Agents; beta-Lactamase Inhibitors; Chemical Phenomena; Chemistry, Physical; Chymotrypsin; Enzyme Inhibitors; Kinetics; Light; Malate Dehydrogenase; Models, Molecular; Molecular Conformation; Scattering, Radiation; Structure-Activity Relationship | 2003 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Riboflavin reduces hyperalgesia and inflammation but not tactile allodynia in the rat.
Topics: Analgesics; Animals; Carrageenan; Enzyme Inhibitors; Female; Glyburide; Hyperalgesia; Inflammation; Motor Activity; Naloxone; Narcotic Antagonists; NG-Nitroarginine Methyl Ester; Pain Measurement; Pain Threshold; Potassium Channel Blockers; Rats; Rats, Wistar; Riboflavin | 2004 |